Developing a biopsy triaging system that aims to identify healthy and benign tissue specimens with high accuracy within seconds.

BeamLine Diagnostics Ltd was set up to commercialise research in to the application of infrared spectroscopy to the diagnosis of cancer. The Company is developing a system that aims to enable rapid, accurate point-of-care screening of biopsies for pre-cancer/cancer. The Company suggests that this will save time and money on more complex analyses and reduce time to diagnosis for both healthy and pre-cancer/cancer patients.

  • Product

    Life Sciences EIS
  • Sector

    Cancer Diagnostics
  • Status

  • HMRC

    Advanced Assurance